微信小陈
微信小章| 产品名称： | 26CB-1 |
|---|---|
| 商品货号： | TS212967 |
| Organism： | Papio hamadryas, baboon, African |
| Cell Type： | lymphoblast |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 2 Cells Contain HERPESVIRUS
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Gender： | male |
| Applications： | The 26CB-1 cell line was established by co-cultivation of baboon splenic lymphocytes with lethally X-irradiated cells of the 1926 marmoset cell line which carries the HVS transforming virus. The cells do not produce immunoglobulin. |
| Derivation： | The 26CB-1 cell line was established by co-cultivation of baboon splenic lymphocytes with lethally X-irradiated cells of the 1926 marmoset cell line which carries the HVS transforming virus. |
| Clinical Data： | male |
| Comments： | The 26CB-1 cell line was established by co-cultivation of baboon splenic lymphocytes with lethally X-irradiated cells of the 1926 marmoset cell line which carries the HVS transforming virus. The cells do not produce immunoglobulin. The cells express a nuclear antigen similar to EBNA and carry Herpesvirus papio. The cells are E rosette positive. |
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
| Subculturing： | Medium Renewal: Every 3 to 5 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 viable cells/ml and do not permit the cell density to exceed 2 X 10 exp6 cells/ml. |
| Name of Depositor： | LA Falk |
| Deposited As： | Papio hamadryas |
| Year of Origin： | 1976 |
| References： | Falk L, et al. Properties of a baboon lymphotropic herpesvirus related to Epstein-Barr virus. Int. J. Cancer 18: 798-807, 1976. PubMed: 186420 Falk LA, et al. Transformation of lymphocytes by Herpesvirus papio. Int. J. Cancer 20: 219-226, 1977. PubMed: 197025 Ohno S, et al. Detection of a nuclear, EBNA-type antigen in apparently EBNA-negative Herpesvirus papio (HVP)-transformed lymphoid lines by the acid-fixed nuclear binding technique. Int. J. Cancer 20: 941-946, 1977. PubMed: 73523 Klein G, et al. Antigen-inducing ability of herpesvirus papio in human and baboon lymphoma lines, compared to Epstein-Barr virus. Intervirology 10: 153-164, 1978. PubMed: 210135 |